I. Barkhatov

发表

Prognostic significance of BAALC overexpression in patients with AML during the posttransplant period

I. Moiseev, B. Afanasyev, T. Gindina, 2018, Cellular Therapy and Transplantation.

Clinical significance of BAALC overexpression for predicting post-transplant relapses in acute myeloid leukemia

B. Afanasyev, N. Mamaev, T. Gindina, 2019, Cellular Therapy and Transplantation.

The Role of BAALC-Expressing Leukemia Precursor Cells in the Pathogenesis of Myelodysplastic Syndromes

S. Bondarenko, I. Barkhatov, E. Morozova, 2022, Clinical oncohematology.

Primary myelodysplastic syndrome with two rare recurrent chromosome abnormalities [t(3q26.2;q22) and trisomy 13] associated with resistance to chemotherapy and hematopoietic stem cell transplantation

B. Afanasyev, N. Mamaev, T. Gindina, 2018, Cellular Therapy and Transplantation.

Impact of recipient marrow stromal cells functional characteristics on engraftment after allo-HSCT

B. Afanasyev, L. Zubarovskaya, A. I. Shakirova, 2016 .

Composition and functional properties of monolayer cell culture from human umbilical cord blood

S. Roumiantsev, B. Afanasyev, I. Barkhatov, 2008 .

Efficacy of Chemotherapy in Acute Leukemia Patients Resistant to Previous Standard Treatment According to the Series Measurement of WT1 Gene Expression

I. Moiseev, N. Mamaev, T. Gindina, 2018 .

A new case of t(6;8)(q27;p12) with "8p11 myeloproliferative syndrome"

Ovechkina, T. Gindina, I. Barkhatov, 2012 .

Successful treatment of extramedullary relapsed/refractory B-acute lymphoblastic leukemia with Inotuzumab ozogamicin before and after allogeneic stem cell transplantation

I. Moiseev, B. Afanasyev, T. Gindina, 2019, Cellular Therapy and Transplantation.

Severe Hypofunction of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Oncohematological Diseases: Incidence, Risk Factors, and Outcomes

I. Moiseev, S. Bondarenko, E. Babenko, 2019, Clinical oncohematology.

Chronic Myeloid Leukemia: Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Tyrosine Kinase Inhibitors

I. Moiseev, B. Afanasyev, N. Mamaev, 2020, Clinical oncohematology.

Differential expression of genes that encode glycolysis enzymes in kidney and lung cancer in humans

N. Oparina, A. Dmitriev, A. Snezhkina, 2013, Russian Journal of Genetics.

The influence of various doses of busulfan in conditioning regimes on outcome of allogeneic hematopoietic stem cell transplantation in children with acute myeloid leukemia

B. Afanasyev, L. Zubarovskaya, I. Barkhatov, 2020, Pediatric Hematology/Oncology and Immunopathology.

Ten-year experience of allogeneic haploidentical hematopoietic stem cell transplantation with non-manipulated grafts in children and adolescents with high-risk acute leukemia

B. Afanasyev, S. Bondarenko, L. Zubarovskaya, 2018, Cellular Therapy and Transplantation.

Current methods and opportunities of next-generation sequencing (NGS) for HLA typing

Youri Serov, Im Barkhatov, Anton S. Klimov, 2016 .

Results of Molecular Monitoring in Posttransplant Period by Means of Series Investigation of WT1 Gene Expression in Patients with Acute Myeloid Leukemia

N. Mamaev, T. Gindina, S. Bondarenko, 2018, Clinical Oncohematology.

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia

S. Bondarenko, L. Zubarovskaya, I. Barkhatov, 2011 .

Features of response to blinatumomab and inotuzumab ozogamicin therapy in patients with relapse/refractory B-cells acute lymphoblastic leukemia in real clinical practice

I. Moiseev, B. Afanasyev, S. Bondarenko, 2020, Cellular Therapy and Transplantation.

Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

I. Moiseev, A. Maschan, E. Parovichnikova, 2019, Clinical oncohematology.

Exosomes as a promising tool for research and molecular diagnostics of myeloproliferative disorders

B. Afanasyev, A. Gorshkov, A. Kremlev, 2019, Cellular Therapy and Transplantation.

Immunotherapy of high-risk infant acute lymphoblastic leukemia using blinatumomab and infusion of donor lymphocytes

I. Barkhatov, A. Frolova, A. Kulagin, 2022, Pediatric Hematology/Oncology and Immunopathology.

The results of allogeneic hematopoietic stem cell transplantation from a matched unrelated and haploidentical donors in children with high-risk infant leukemia in first and second remissions

B. Afanasyev, L. Zubarovskaya, I. Barkhatov, 2020, Pediatric Hematology/Oncology and Immunopathology.

The prognostic value of HLA loss of heterozygosity after allogeneic hematopoietic stem cell transplantation in children with relapsed acute leukemia

I. Barkhatov, A. Frolova, A. Kulagin, 2023, Pediatric Hematology/Oncology and Immunopathology.

Difficulties of primary diagnosis in patients with suspected systemic mastocytosis

I. Barkhatov, I. Moiseev, M. V. Barabanshchikova, 2024, Oncohematology.